News

Hepatitis outlook: July 2016


 

References

Sustained virologic response can be attained with pegylated interferon-alpha plus ribavirin combination therapy in hepatitis C virus–infected patients, but a relapse may occur in some patients, according to a recent study.

A quantitative HBsAg test can be used to ascertain high levels of hepatitis B viremia in women who might transmit the virus to their children, rather than a test for HBeAg or HBV DNA, according to a research letter in Hepatology.

A Chinese study found a robust relationship between Helicobacter pylori infection and chronic hepatitis B. This is especially true during hepatitis B virus progression.

The prevalence of antihepatitis E virus (HEV) antibodies was 49% (153/313) among blood donors in central Italy, according to a study published in Eurosurveillance. The authors said HEV infection is hyperendemic among blood donors (80% men, 18- to 64-years-old) from central Italy and associated with local dietary habits, such as eating raw dried pig liver sausage.

rpizzi@frontlinemedcom.com

On Twitter @richpizzi

Pages

Recommended Reading

Hepatitis A and B combo vaccinations remain effective after 15 years
HCV Hub
Chronic HCV boosts hospitalization risk, not just for liver
HCV Hub
VIDEO: Nearly half of Medicaid patients denied antivirals for HCV
HCV Hub
HIV/HCV coinfection further raises inflammatory markers
HCV Hub
Hepatitis outlook: May 2016
HCV Hub
Women underrepresented as GI division chiefs
HCV Hub
New HCV test approach could cut costs, streamline diagnosis
HCV Hub
HIV patients with elevated ALT at significant risk of chronic liver disease
HCV Hub
Hepatitis disease burden continues to rise
HCV Hub
Hepatitis C infection rates rising in women, young children
HCV Hub